Skip to main content
. Author manuscript; available in PMC: 2011 Oct 1.
Published in final edited form as: Chem Biol Drug Des. 2010 Aug 30;76(4):293–304. doi: 10.1111/j.1747-0285.2010.01021.x

Figure 6.

Figure 6

Competitive ELISAs using antibody A, which is specific for PAO pilin. In Panels A, B, and C, PAO pilin is the competitor. In Panel A, PAO pilin is plated; in Panel B, PAO (KSK) mutant pilin is plated and in Panel C PAK (ADN) mutant pilin is plated. IC50, the concentration of pilin protein resulting in 50% inhibition of antibody binding in the competitive ELISA.